- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
V
VYNE
Vyne Therapeutics Inc
0.6147
+0.0047+0.77%Opening11:54 04/09 EDT
OPEN/PREV CLOSE0.6100/0.6100
TODAY RANGE0.6021-0.6232
VOL10.89K
MARKET CAP20.48M
52 WEEK RANGE0.2805-1.993
AVG VOL (3M)312.07K
% TURNOVER0.03%
TURNOVER--
P/E (TTM)-0.9927
% RANGE3.46%
EPS(TTM)-0.6192
P/E(FORWARD)-0.9314
P/B0.7378
BVPS0.8332
DIVIDEND--
P/S35.95
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.53M
SHARES OUTSTANDING33.32M
NEXT EARNINGS05/06-05/11
FREE FLOAT31.78M
LOT SIZE1
EX-DATE02/13/2023
News
Press Releases
Financial Reports
Profile
TipRanks·03/12 01:04
VYNE Therapeutics Granted Nasdaq Extension to Regain Compliance
TipRanks·01/30 21:32
VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience
Reuters·01/30 21:11
Vyne Therapeutics Amends Merger Agreement With Yarrow Bioscience
Benzinga·01/26 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga·12/18/2025 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·12/18/2025 14:25
3 Penny Stocks to Watch Now, 12/18/25
PR Newswire·12/17/2025 21:35
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of VYNE Therapeutics Inc. (NASDAQ: VYNE)
Benzinga·12/17/2025 17:06
12 Health Care Stocks Moving In Wednesday's Intraday Session
Seeking Alpha·12/17/2025 16:18
VYNE Therapeutics to merge With Yarrow Bioscience, secures $200M financing; shares up
Benzinga·12/17/2025 14:39
Dow Jumps 150 Points; Jabil Posts Upbeat Earnings
Dow Jones·12/17/2025 13:47
Vyne Therapeutics, Yarrow Bioscience to Merge
TipRanks·12/17/2025 13:46
VYNE Therapeutics Announces Merger with Yarrow Bioscience
Same Industry
Name/Symbol
Change%
Price